Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bruno Alves Silva"'
Autor:
Diana Azeredo Rangel, Cristiane Varella Lisboa, Roberto Leonan Morim Novaes, Bruno Alves Silva, Renan de França Souza, Ana Maria Jansen, Ricardo Moratelli, André Luiz Rodrigues Roque
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 7, p e0007527 (2019)
We studied infection by Trypanosomatidae in bats captured in two areas with different degradation levels in the Atlantic Forest of Rio de Janeiro state: Reserva Ecológica de Guapiaçu (REGUA) and Estação Fiocruz Mata Atlântica (EFMA). Furthermore
Externí odkaz:
https://doaj.org/article/5a94a7636f3e43118f74b1476535ed13
Autor:
Antônio Bruno Alves-Silva, Bruna Alves Fenerich, Natasha Peixoto Fonseca, Jaqueline Cristina Fernandes, Juan Luiz Coelho-Silva, Diego Antonio Pereira-Martins, Thiago Mantello Bianco, Priscila Santos Scheucher, Eduardo Magalhães Rego, Fernando Chahud, João Agostinho Machado-Neto, Lorena Lôbo Figueiredo-Pontes, Fabiola Traina
Publikováno v:
Investigational New Drugs. 40:576-585
Autor:
Natasha Peixoto Fonseca, Bruna Alves Fenerich, Diego A Pereira-Martins, Pedro Manoel Marques Garibaldi, Juan L Coelho-Silva, Antonio Bruno Alves Silva, Jaqueline Cristina Fernandes, Cleide Lucia Silva, Eduardo M Rego, João Agostinho Machado-Neto, Fabiola Traina
Publikováno v:
Blood. 140:12153-12154
Autor:
Jaqueline Cristina, Fernandes, Bruna Alves, Fenerich, Antônio Bruno, Alves-Silva, Natasha Peixoto, Fonseca, Juan Luiz, Coelho-Silva, Priscila Santos, Scheucher, Eduardo Magalhães, Rego, Lorena Lôbo, Figueiredo-Pontes, João Agostinho, Machado-Neto, Fabiola, Traina
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 83
Myeloproliferative neoplasms (MPN) belong to a group of clonal diseases of hematopoietic stem cells characterized by aberrant proliferation of mature myeloid lineages. The constitutive activation of the JAK2/STAT signaling pathway is now well establi
Autor:
Jaqueline Cristina Fernandes, Bruna Alves Fenerich, Antônio Bruno Alves-Silva, Natasha Peixoto Fonseca, Juan Luiz Coelho-Silva, Priscila Santos Scheucher, Eduardo Magalhães Rego, Lorena Lôbo Figueiredo-Pontes, João Agostinho Machado-Neto, Fabiola Traina
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc3e462003ac25307ca0a710d1482dca
Autor:
Antônio Bruno, Alves-Silva, Bruna Alves, Fenerich, Natasha Peixoto, Fonseca, Jaqueline Cristina, Fernandes, Juan Luiz, Coelho-Silva, Diego Antonio, Pereira-Martins, Thiago Mantello, Bianco, Priscila Santos, Scheucher, Eduardo Magalhães, Rego, Fernando, Chahud, João Agostinho, Machado-Neto, Lorena Lôbo, Figueiredo-Pontes, Fabiola, Traina
Publikováno v:
Investigational new drugs. 40(3)
Myeloproliferative neoplasms (MPN) are disorders characterized by an alteration at the hematopoietic stem cell (HSC) level, where the JAK2 mutation is the most common genetic alteration found in classic MPN (polycythemia vera, essential thrombocythem
Autor:
Ann Mullally, Susumu Kobayashi, Antonio Bruno Alves Silva, Cleide Lucia Silva, Eduardo Magalhães Rego, Juan L Coelho-Silva, Fabiola Traina, Diego A Pereira-Martins, Thiago Mantello Bianco, Lorena Lobo de Figueiredo-Pontes, Priscila Santos Scheucher, Isabel Weinhäuser
Publikováno v:
Blood. 134:2977-2977
Background: The Jak2V617F mutation represents the most common molecular abnormality present in Philadelphia chromosome-negative Classical Myeloproliferative Neoplasms (Ph-neg MPNs). The differential expression of genes/proteins between the hematopoie
Autor:
Juan L Coelho-Silva, João Agostinho Machado-Neto, Thiago Mantello Bianco, Fernando Chahud, NP Fonseca, Eduardo Magalhães Rego, Diego A Pereira-Martins, Antonio Bruno Alves Silva, Lorena Lobo de Figueiredo-Pontes, Fabiola Traina, Isabel Weinhäuser
Publikováno v:
Blood. 134:1682-1682
Background : Preclinical rationale of metformin treatment for myeloproliferative neoplasms (MPN) has recently been demonstrated (Cell Death Dis. 2018;9(3):311). Current MPN treatment options are mainly directed to symptoms and have not greatly improv